Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Targeted Therapeutics market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Targeted Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Targeted Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Glaxosmithkline PLC
Bristol-Myers Squibb
Merck & Co, Inc
Novartis International AG
Amgen Inc
Astrazeneca
F Hoffmann-La Roche AG
Merck & Co., Inc.
Johnson & Johnson.
F. Hoffmann-La Roche AG
By Type:
Oncology Drugs
Immunotherapy
Cell Therapy
Monoclonal Antibodies
Others
By End-User:
Pediatrics
Middle Age
Senior Age
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Targeted Therapeutics Market
-
1.3 Market Segment by Type
1.3.1 Japan Targeted Therapeutics Market Size and Growth Rate of Oncology Drugs from 2014 to 2026
1.3.2 Japan Targeted Therapeutics Market Size and Growth Rate of Immunotherapy from 2014 to 2026
1.3.3 Japan Targeted Therapeutics Market Size and Growth Rate of Cell Therapy from 2014 to 2026
1.3.4 Japan Targeted Therapeutics Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026
1.3.5 Japan Targeted Therapeutics Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Targeted Therapeutics Market Size and Growth Rate of Pediatrics from 2014 to 2026
1.4.2 Japan Targeted Therapeutics Market Size and Growth Rate of Middle Age from 2014 to 2026
1.4.3 Japan Targeted Therapeutics Market Size and Growth Rate of Senior Age from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Targeted Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Targeted Therapeutics by Major Types
3.4.1 Market Size and Growth Rate of Oncology Drugs
3.4.2 Market Size and Growth Rate of Immunotherapy
3.4.3 Market Size and Growth Rate of Cell Therapy
3.4.4 Market Size and Growth Rate of Monoclonal Antibodies
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Targeted Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Targeted Therapeutics by Major End-Users
4.4.1 Market Size and Growth Rate of Targeted Therapeutics in Pediatrics
4.4.2 Market Size and Growth Rate of Targeted Therapeutics in Middle Age
4.4.3 Market Size and Growth Rate of Targeted Therapeutics in Senior Age
5 Market Analysis by Regions
-
5.1 Japan Targeted Therapeutics Production Analysis by Regions
-
5.2 Japan Targeted Therapeutics Consumption Analysis by Regions
6 Hokkaido Targeted Therapeutics Landscape Analysis
-
6.1 Hokkaido Targeted Therapeutics Landscape Analysis by Major Types
-
6.2 Hokkaido Targeted Therapeutics Landscape Analysis by Major End-Users
7 Tohoku Targeted Therapeutics Landscape Analysis
-
7.1 Tohoku Targeted Therapeutics Landscape Analysis by Major Types
-
7.2 Tohoku Targeted Therapeutics Landscape Analysis by Major End-Users
8 Kanto Targeted Therapeutics Landscape Analysis
-
8.1 Kanto Targeted Therapeutics Landscape Analysis by Major Types
-
8.2 Kanto Targeted Therapeutics Landscape Analysis by Major End-Users
9 Chubu Targeted Therapeutics Landscape Analysis
-
9.1 Chubu Targeted Therapeutics Landscape Analysis by Major Types
-
9.2 Chubu Targeted Therapeutics Landscape Analysis by Major End-Users
10 Kinki Targeted Therapeutics Landscape Analysis
-
10.1 Kinki Targeted Therapeutics Landscape Analysis by Major Types
-
10.2 Kinki Targeted Therapeutics Landscape Analysis by Major End-Users
11 Chugoku Targeted Therapeutics Landscape Analysis
-
11.1 Chugoku Targeted Therapeutics Landscape Analysis by Major Types
-
11.2 Chugoku Targeted Therapeutics Landscape Analysis by Major End-Users
12 Shikoku Targeted Therapeutics Landscape Analysis
-
12.1 Shikoku Targeted Therapeutics Landscape Analysis by Major Types
-
12.2 Shikoku Targeted Therapeutics Landscape Analysis by Major End-Users
13 Kyushu Targeted Therapeutics Landscape Analysis
-
13.1 Kyushu Targeted Therapeutics Landscape Analysis by Major Types
-
13.2 Kyushu Targeted Therapeutics Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Glaxosmithkline PLC
14.1.1 Glaxosmithkline PLC Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Bristol-Myers Squibb
14.2.1 Bristol-Myers Squibb Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Merck & Co, Inc
14.3.1 Merck & Co, Inc Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Novartis International AG
14.4.1 Novartis International AG Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Amgen Inc
14.5.1 Amgen Inc Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Astrazeneca
14.6.1 Astrazeneca Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 F Hoffmann-La Roche AG
14.7.1 F Hoffmann-La Roche AG Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Merck & Co., Inc.
14.8.1 Merck & Co., Inc. Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Johnson & Johnson.
14.9.1 Johnson & Johnson. Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 F. Hoffmann-La Roche AG
14.10.1 F. Hoffmann-La Roche AG Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 118 Figures and 166 Tables)
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Oncology Drugs from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Immunotherapy from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Cell Therapy from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Pediatrics from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Middle Age from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Senior Age from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Targeted Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Targeted Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Targeted Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Targeted Therapeutics by Different Types from 2014 to 2026
-
Table Consumption Share of Targeted Therapeutics by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Oncology Drugs
Figure Market Size and Growth Rate of Immunotherapy
Figure Market Size and Growth Rate of Cell Therapy
Figure Market Size and Growth Rate of Monoclonal Antibodies
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Targeted Therapeutics by Different End-Users from 2014 to 2026
-
Table Consumption Share of Targeted Therapeutics by Different End-Users from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Pediatrics from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Middle Age from 2014 to 2026
Figure Japan Targeted Therapeutics Market Size and Growth Rate of Senior Age from 2014 to 2026
-
Table Japan Targeted Therapeutics Production by Regions
-
Table Japan Targeted Therapeutics Production Share by Regions
-
Figure Japan Targeted Therapeutics Production Share by Regions in 2014
-
Figure Japan Targeted Therapeutics Production Share by Regions in 2018
-
Figure Japan Targeted Therapeutics Production Share by Regions in 2026
-
Table Japan Targeted Therapeutics Consumption by Regions
-
Table Japan Targeted Therapeutics Consumption Share by Regions
-
Figure Japan Targeted Therapeutics Consumption Share by Regions in 2014
-
Figure Japan Targeted Therapeutics Consumption Share by Regions in 2018
-
Figure Japan Targeted Therapeutics Consumption Share by Regions in 2026
-
Table Hokkaido Targeted Therapeutics Consumption by Types from 2014 to 2026
-
Table Hokkaido Targeted Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Targeted Therapeutics Consumption Share by Types in 2014
-
Figure Hokkaido Targeted Therapeutics Consumption Share by Types in 2018
-
Figure Hokkaido Targeted Therapeutics Consumption Share by Types in 2026
-
Table Hokkaido Targeted Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Targeted Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Targeted Therapeutics Consumption Share by End-Users in 2014
-
Figure Hokkaido Targeted Therapeutics Consumption Share by End-Users in 2018
-
Figure Hokkaido Targeted Therapeutics Consumption Share by End-Users in 2026
-
Table Tohoku Targeted Therapeutics Consumption by Types from 2014 to 2026
-
Table Tohoku Targeted Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Targeted Therapeutics Consumption Share by Types in 2014
-
Figure Tohoku Targeted Therapeutics Consumption Share by Types in 2018
-
Figure Tohoku Targeted Therapeutics Consumption Share by Types in 2026
-
Table Tohoku Targeted Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Tohoku Targeted Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Targeted Therapeutics Consumption Share by End-Users in 2014
-
Figure Tohoku Targeted Therapeutics Consumption Share by End-Users in 2018
-
Figure Tohoku Targeted Therapeutics Consumption Share by End-Users in 2026
-
Table Kanto Targeted Therapeutics Consumption by Types from 2014 to 2026
-
Table Kanto Targeted Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kanto Targeted Therapeutics Consumption Share by Types in 2014
-
Figure Kanto Targeted Therapeutics Consumption Share by Types in 2018
-
Figure Kanto Targeted Therapeutics Consumption Share by Types in 2026
-
Table Kanto Targeted Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kanto Targeted Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Targeted Therapeutics Consumption Share by End-Users in 2014
-
Figure Kanto Targeted Therapeutics Consumption Share by End-Users in 2018
-
Figure Kanto Targeted Therapeutics Consumption Share by End-Users in 2026
-
Table Chubu Targeted Therapeutics Consumption by Types from 2014 to 2026
-
Table Chubu Targeted Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Chubu Targeted Therapeutics Consumption Share by Types in 2014
-
Figure Chubu Targeted Therapeutics Consumption Share by Types in 2018
-
Figure Chubu Targeted Therapeutics Consumption Share by Types in 2026
-
Table Chubu Targeted Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Chubu Targeted Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Targeted Therapeutics Consumption Share by End-Users in 2014
-
Figure Chubu Targeted Therapeutics Consumption Share by End-Users in 2018
-
Figure Chubu Targeted Therapeutics Consumption Share by End-Users in 2026
-
Table Kinki Targeted Therapeutics Consumption by Types from 2014 to 2026
-
Table Kinki Targeted Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kinki Targeted Therapeutics Consumption Share by Types in 2014
-
Figure Kinki Targeted Therapeutics Consumption Share by Types in 2018
-
Figure Kinki Targeted Therapeutics Consumption Share by Types in 2026
-
Table Kinki Targeted Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kinki Targeted Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Targeted Therapeutics Consumption Share by End-Users in 2014
-
Figure Kinki Targeted Therapeutics Consumption Share by End-Users in 2018
-
Figure Kinki Targeted Therapeutics Consumption Share by End-Users in 2026
-
Table Chugoku Targeted Therapeutics Consumption by Types from 2014 to 2026
-
Table Chugoku Targeted Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Targeted Therapeutics Consumption Share by Types in 2014
-
Figure Chugoku Targeted Therapeutics Consumption Share by Types in 2018
-
Figure Chugoku Targeted Therapeutics Consumption Share by Types in 2026
-
Table Chugoku Targeted Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Chugoku Targeted Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Targeted Therapeutics Consumption Share by End-Users in 2014
-
Figure Chugoku Targeted Therapeutics Consumption Share by End-Users in 2018
-
Figure Chugoku Targeted Therapeutics Consumption Share by End-Users in 2026
-
Table Shikoku Targeted Therapeutics Consumption by Types from 2014 to 2026
-
Table Shikoku Targeted Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Targeted Therapeutics Consumption Share by Types in 2014
-
Figure Shikoku Targeted Therapeutics Consumption Share by Types in 2018
-
Figure Shikoku Targeted Therapeutics Consumption Share by Types in 2026
-
Table Shikoku Targeted Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Shikoku Targeted Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Targeted Therapeutics Consumption Share by End-Users in 2014
-
Figure Shikoku Targeted Therapeutics Consumption Share by End-Users in 2018
-
Figure Shikoku Targeted Therapeutics Consumption Share by End-Users in 2026
-
Table Kyushu Targeted Therapeutics Consumption by Types from 2014 to 2026
-
Table Kyushu Targeted Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Targeted Therapeutics Consumption Share by Types in 2014
-
Figure Kyushu Targeted Therapeutics Consumption Share by Types in 2018
-
Figure Kyushu Targeted Therapeutics Consumption Share by Types in 2026
-
Table Kyushu Targeted Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kyushu Targeted Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Targeted Therapeutics Consumption Share by End-Users in 2014
-
Figure Kyushu Targeted Therapeutics Consumption Share by End-Users in 2018
-
Figure Kyushu Targeted Therapeutics Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Glaxosmithkline PLC
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glaxosmithkline PLC
Figure Sales and Growth Rate Analysis of Glaxosmithkline PLC
Figure Revenue and Market Share Analysis of Glaxosmithkline PLC
Table Product and Service Introduction of Glaxosmithkline PLC
Table Company Profile and Development Status of Bristol-Myers Squibb
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
Table Product and Service Introduction of Bristol-Myers Squibb
Table Company Profile and Development Status of Merck & Co, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc
Figure Sales and Growth Rate Analysis of Merck & Co, Inc
Figure Revenue and Market Share Analysis of Merck & Co, Inc
Table Product and Service Introduction of Merck & Co, Inc
Table Company Profile and Development Status of Novartis International AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG
Figure Sales and Growth Rate Analysis of Novartis International AG
Figure Revenue and Market Share Analysis of Novartis International AG
Table Product and Service Introduction of Novartis International AG
Table Company Profile and Development Status of Amgen Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc
Figure Sales and Growth Rate Analysis of Amgen Inc
Figure Revenue and Market Share Analysis of Amgen Inc
Table Product and Service Introduction of Amgen Inc
Table Company Profile and Development Status of Astrazeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca
Figure Sales and Growth Rate Analysis of Astrazeneca
Figure Revenue and Market Share Analysis of Astrazeneca
Table Product and Service Introduction of Astrazeneca
Table Company Profile and Development Status of F Hoffmann-La Roche AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche AG
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche AG
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche AG
Table Product and Service Introduction of F Hoffmann-La Roche AG
Table Company Profile and Development Status of Merck & Co., Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co., Inc.
Figure Sales and Growth Rate Analysis of Merck & Co., Inc.
Figure Revenue and Market Share Analysis of Merck & Co., Inc.
Table Product and Service Introduction of Merck & Co., Inc.
Table Company Profile and Development Status of Johnson & Johnson.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson.
Figure Sales and Growth Rate Analysis of Johnson & Johnson.
Figure Revenue and Market Share Analysis of Johnson & Johnson.
Table Product and Service Introduction of Johnson & Johnson.
Table Company Profile and Development Status of F. Hoffmann-La Roche AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche AG
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche AG
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche AG
Table Product and Service Introduction of F. Hoffmann-La Roche AG
-
